Thomas Dietz - Jan 23, 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Director
Signature
/s/ Thomas J. Dietz
Stock symbol
EIGR
Transactions as of
Jan 23, 2023
Transactions value $
$71,580
Form type
4
Date filed
1/25/2023, 07:54 PM
Previous filing
Dec 27, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Purchase $71.6K +50K $1.43 50K Jan 23, 2023 By Trust F1, F2
holding EIGR Common Stock 21K Jan 23, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F2 These shares are held directly by the Dietz Family Trust, for which the reporting person and his spouse serve as co-trustees.